[1]
Pietrzykowska, J. et al. 2024. Significance of zoledronic acid in the adjuvant therapy in patients with breast cancer. Polish Journal of Public Health. 134, (Jul. 2024), 37–41. DOI:https://doi.org/10.12923/2083-4829/2024-0009.